ZP3022 25 mg | ≥95% Cayman Chemical A dual GLP-1R and CCK2 receptor agonist More Information Supplier Page × ZP3022
ZP3022 10 mg | ≥95% Cayman Chemical A dual GLP-1R and CCK2 receptor agonist More Information Supplier Page × ZP3022
ZP3022 1 mg | ≥95% Cayman Chemical A dual GLP-1R and CCK2 receptor agonist More Information Supplier Page × ZP3022
2,4-Dinitrobenzenesulfonic Acid (sodium salt) 5 g | ≥98% Cayman Chemical A hapten More Information Supplier Page × 2,4-Dinitrobenzenesulfonic Acid (sodium salt)
2,4-Dinitrobenzenesulfonic Acid (sodium salt) 25 g | ≥98% Cayman Chemical A hapten More Information Supplier Page × 2,4-Dinitrobenzenesulfonic Acid (sodium salt)
2,4-Dinitrobenzenesulfonic Acid (sodium salt) 10 g | ≥98% Cayman Chemical A hapten More Information Supplier Page × 2,4-Dinitrobenzenesulfonic Acid (sodium salt)
GPR3 Agonist 2 5 mg | ≥98% Cayman Chemical A GPR3 agonist More Information Supplier Page × GPR3 Agonist 2
GPR3 Agonist 2 10 mg | ≥98% Cayman Chemical A GPR3 agonist More Information Supplier Page × GPR3 Agonist 2
GPR3 Agonist 2 1 mg | ≥98% Cayman Chemical A GPR3 agonist More Information Supplier Page × GPR3 Agonist 2
Anti-NASH Agent 1 50 mg | ≥98% Cayman Chemical An anti-NASH agent More Information Supplier Page × Anti-NASH Agent 1
